AON
25
4
AXP
63
3
LMT
29
-5
NDAQ
46
2
FSLR
50
6
TROW
37
8
KHC
11
2
UA
48
6
CSCO
63
5
IPG
43
3
MAR
57
3
CAT
47
3
CPB
24
2
MS
64
3
APH
53
3
FMC
23
7
IP
53
3
MDLZ
28
2
A
43
2
JNPR
59
3
AON
25
4
AXP
63
3
LMT
29
-5
NDAQ
46
2
FSLR
50
6
TROW
37
8
KHC
11
2
UA
48
6
CSCO
63
5
IPG
43
3
MAR
57
3
CAT
47
3
CPB
24
2
MS
64
3
APH
53
3
FMC
23
7
IP
53
3
MDLZ
28
2
A
43
2
JNPR
59
3
Financhill
Back

Zevra Therapeutics Stock Predictions

This Tech Company Grew 32,481%...

This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
44

ZVRA
Zevra Therapeutics

Last Price:
$8.58
Seasonality Move:
-0.81%

7 Day Trial

ALL ACCESS PASS

$ 7

Elon Musk Predicts MAJOR Crisis in Trump's First Year

See Why Investors are Pouring Mountains of Cash into Certain Companies Trump Wants to Solve the Problem.

Zevra Therapeutics Stock Forecast

  • Over the next 52 weeks, Zevra Therapeutics has on average historically fallen by 6.5% based on the past 9 years of stock performance.
  • Zevra Therapeutics has fallen lower in 5 of those 9 years over the subsequent 52-week period, corresponding to a historical accuracy of 55.56%
  • Is Zevra Therapeutics Stock Undervalued?
    The current Zevra Therapeutics [ZVRA] share price is $8.49. The Score for ZVRA is 44, which is 12% below its historic median score of 50, and infers higher risk than normal.
  • ZVRA is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.

Will Zevra Therapeutics Stock Go Up Next Year?

  • Over the next 52 weeks, Zevra Therapeutics has on average historically fallen by 6.5% based on the past 9 years of stock performance.

Zevra Therapeutics Stock Rating

Sell
44
Zevra Therapeutics (ZVRA) is a Sell

Is Zevra Therapeutics overpriced?

  • Zevra Therapeutics has fallen lower in 5 of those 9 years over the subsequent 52-week period, corresponding to a historical accuracy of 55.56%

Zevra Therapeutics Stock Price History

Is ZVRA stock going to rise?

  • The current trend is relatively stagnant and ZVRA is experiencing slight selling pressure.

Stock Information

Stock Info

Exchange:
NASDAQ
Country:
United States
Industry:
Pharmaceuticals
Sector:
Health Care
Type:
stock
Website:
zevra.com

52-Week Data

52-Week High:
9.76
52-Week Low:
4.20

Prediction Charts

Market Cap:
453.2M
Price in USD:
8.49
Volume:
2.5M
Beta:
1.82

Technical Analysis

SMA50:
8.69
SMA100:
8.04
SMA200:
6.59
52-Wk Change:
78.93%

Stock Predictions

  • Is Zevra Therapeutics stock public?
    Yes, Zevra Therapeutics is a publicly traded company.
  • What is the Zevra Therapeutics stock quote today?
    The Zevra Therapeutics stock price is 8.49 USD today.
  • How to buy Zevra Therapeutics stock online?
    You can buy Zevra Therapeutics shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

14-Day Historical Data

Date Opening Closing Minimum Maximum
Dec-3 9.64 9.40 9.64 9.25
Dec-4 9.40 9.18 9.51 9.12
Dec-5 9.15 9.00 9.35 8.94
Dec-6 9.03 9.15 9.26 8.99
Dec-9 9.05 8.86 9.15 8.65
Dec-10 8.88 8.90 9.06 8.75
Dec-11 8.92 8.84 8.92 8.64
Dec-12 8.75 8.44 8.93 8.36
Dec-13 8.39 8.48 8.74 8.35
Dec-16 8.57 8.44 8.79 8.37
Dec-17 8.40 8.48 8.66 8.28
Dec-18 8.50 8.29 8.73 8.17
Dec-19 8.35 8.54 8.65 8.23
Dec-20 8.43 8.49 8.83 8.34

Zevra Therapeutics Earnings

Zevra Therapeutics Earnings Report: Per Share Zevra Therapeutics Earnings Q1 Q2 Q3 and Q4 last year and next year.

Zevra Therapeutics Forecast Revenue Growth

Zevra Therapeutics Stock Analysis: Historical quarterly revenues per share for Zevra Therapeutics and historical quarterly revenue growth:

  • Analysts estimate an earnings decrease this quarter of $0.33 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.75 per share, and an increase next year of $1.62 per share.

* Zevra Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.